RAS (KRAS and NRAS) Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer who receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy - ICD-10-CM Quality Payment Program Measure
| Quality Measure | Description | High Priority | Submission Methods |
|---|---|---|---|
| RAS (KRAS and NRAS) Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer who receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy | Percentage of adult patients (aged 18 or over) with metastatic colorectal cancer who receive anti-epidermal growth factor receptor monoclonal antibody therapy for whom RAS (KRAS and NRAS) gene mutation testing was performed. | NO | Registry |
Linked ICD-10 Codes
The following ICD-10-CM codes are linked to the quality measure ras (kras and nras) gene mutation testing performed for patients with metastatic colorectal cancer who receive anti-epidermal growth factor receptor (egfr) monoclonal antibody therapy when used as part of a patient's medical record. This Quality Measure is part of Medicare's Quality Payment Program (QPP).
| ICD Code | Description | Category |
|---|